COSCIENS Biopharma Inc. Total Liabilities
COSCIENS Biopharma Inc. (CSCIF) had Total Liabilities of $17.59 million as of 2025-12-31, per its 20-F filed 2026-03-25.
Financial Statements › Notes
ifrs-full:Liabilities · last filed 2026-03-25
- 2025-12-31: Liabilities $17.59M.
- 2025-09-30: Liabilities $18.78M.
- 2025-06-30: Liabilities $20.46M.
- 2025-03-31: Liabilities $21.00M.
USD
| Period end | Liabilities | Liabilities as first filed |
|---|---|---|
| 2025-12-31 | $17.59M 20-F · filed 2026-03-25 | |
| 2025-09-30 | $18.78M 6-K · filed 2025-11-12 | |
| 2025-06-30 | $20.46M 6-K · filed 2025-08-14 | |
| 2025-03-31 | $21.00M 6-K · filed 2025-05-13 | |
| 2024-12-31 | $21.91M 20-F · filed 2026-03-25 | |
| 2024-09-30 | $23.75M 6-K · filed 2024-11-12 | |
| 2024-06-30 | $23.82M 6-K · filed 2024-08-13 | |
| 2024-03-31 | $18.82M 6-K · filed 2024-05-16 | |
| 2023-12-31 | $2.71M 20-F · filed 2025-04-09 | $18.82M 20-F · filed 2024-03-27 |
| 2023-09-30 | $16.21M 6-K · filed 2023-11-09 | |
| 2023-06-30 | $17.40M 6-K · filed 2023-08-09 | |
| 2023-03-31 | $20.07M 6-K · filed 2023-05-09 | |
| 2022-12-31 | $4.02M 20-F · filed 2025-04-09 | $20.25M 20-F · filed 2023-03-23 |
| 2022-09-30 | $17.19M 6-K · filed 2022-11-03 | |
| 2022-06-30 | $17.53M 6-K/A · filed 2022-08-04 | |
| 2022-03-31 | $23.18M 6-K · filed 2022-05-11 | |
| 2021-12-31 | $27.12M 20-F/A · filed 2024-02-15 | |
| 2021-09-30 | $22.12M 6-K · filed 2021-11-04 | |
| 2021-06-30 | $23.00M 6-K · filed 2021-08-05 | |
| 2021-03-31 | $22.84M 6-K · filed 2021-05-05 | |
| 2020-12-31 | $23.79M 20-F · filed 2022-03-29 | $24.07M 40-F · filed 2021-03-25 |
| 2020-09-30 | $17.12M 6-K · filed 2020-11-05 | |
| 2020-06-30 | $16.74M 6-K · filed 2020-08-06 | |
| 2020-03-31 | $17.95M 6-K/A · filed 2020-05-11 | |
| 2019-12-31 | $22.44M 40-F/A · filed 2021-03-29 | |
| 2019-09-30 | $23.70M 6-K · filed 2019-11-07 | |
| 2019-06-30 | $23.78M 6-K · filed 2019-08-13 | |
| 2018-12-31 | $23.10M 20-F · filed 2020-03-31 | |
| 2017-12-31 | $24.98M 20-F · filed 2019-04-01 | |
| 2016-12-31 | $25.45M 20-F · filed 2018-03-28 |
CAD
| Period end | Liabilities |
|---|---|
| 2023-12-31 | 3.59M CAD 20-F · filed 2025-04-09 |
| 2022-12-31 | 5.45M CAD 20-F · filed 2025-04-09 |